This is a Validated Antibody Database (VAD) review about equine ENG, based on 5 published articles (read how Labome selects the articles), using ENG antibody in all methods. It is aimed to help Labome visitors find the most suited ENG antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ENG synonym: CD105; endoglin; endoglin (Osler-Rendu-Weber syndrome 1)
Invitrogen
mouse monoclonal (SN6) |
| In order to explore the contribution of CD105 to leukemogenesis, Invitrogen ENG antibody (eBioscience, SN6) was used in flow cytometry on human samples (fig 1a). Blood (2017) ncbi |
mouse monoclonal (SN6) |
| In order to develop mesenchymal stem cells derivatives to treat Hemophilia B, Invitrogen ENG antibody (Thermo Fisher Scientific, MA1-80944) was used in flow cytometry on human samples at 1:50 (fig 2c). Mol Med Rep (2017) ncbi |
mouse monoclonal (SN6) |
| In order to describe and differentiate human amniotic fluid mesenchymal stem cells into endothelial-like cells, Invitrogen ENG antibody (Pierce, MA1-80944) was used in flow cytometry on human samples (fig 2). Acta Histochem (2017) ncbi |
mouse monoclonal (SN6) |
| In order to study the differentiation of chondrocyte-like cells from mesenchymal stem cells, Invitrogen ENG antibody (Pierce Biotechnology, MA1-80944) was used in flow cytometry on human samples (fig 3) and in immunocytochemistry on human samples (fig 2). Acta Histochem (2016) ncbi |
mouse monoclonal (SN6) |
| In order to assess the susceptibility of fetal membranes-derived mesenchymal stromal/stem cells to all members of the human Herpesviridae family, Invitrogen ENG antibody (Caltag Laboratories, clone SN6) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments